A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy

Blood

Volumn 90, Issue 11, 1997, Pages 4313-4320

  Shpall, Elizabeth J ^a   Fred LeMaistre, C ^b   Holland, Kent ^b   Ball, Edward ^b   Jones, Roy B ^b   Saral, Rein ^b   Jacobs, Cindy ^b   Heimfeld, Shelly ^b   Berenson, Ronald ^b   Champlin, Richard ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CRYOPRESERVATION; DIASTOLIC BLOOD PRESSURE; HEMATOPOIESIS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; PRIORITY JOURNAL; STEM CELL; SYSTOLIC BLOOD PRESSURE;

EID: 1842417173     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4313.4313_4313_4320     Document Type: Article

References (33)

1. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827, 1994
2. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6:1368, 1988
3. Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC Jr, Jones R, Shpall E: High-dose chemotherapy and autologous bone marrow support after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132, 1993
4. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986
5. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner GD, Bernstein ID: Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951, 1988
6. Shpall EJ, Jones RB, Franklin W, Curiel T, Bitter M, Claman H, Archer PG, Bearman S, Stemmer S, Myers S, Purdy M, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson R: Transplantation of enriched CD34 positive (+) autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34+ peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
7. Gorin N, Najman A, Salmon C, Muller JY, Petit JC, David R, Stachowiak J, Hirsch Marie F, Parlier Y, Duhamel G: High dose combination chemotherapy with and without autologous bone marrow transplantation for the treatment of acute leukemia and other malignant diseases. Eur J Cancer 15:1113, 1979
8. Davis JM, Rowley SD, Braine HG, Piantodosi S, Santos GW: Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 75:781, 1990
9. O'Donnell JR, Burnett AK, Sheehan T, Tansey P, McDonald GA: Safety of dimethylsufoxide. Lancet 1:498, 1981
10. Samoszuk M, Reid M, Toy P: Intravenous dimethyl-sulfoxide therapy causes severe hemolysis mimicking a hemolytic transfusion reaction. Transfusion 23:405, 1983
11. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NKC, McCullough J: Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 31:521, 1991
12. Berenson RJ, Bensinger WI, Kalamasz D, Schuening F, Deeg HJ, Storb R: Avidin-biotin immunoadsorption: A technique to purify cells and its potential applications, in Gale RP, Champlin R (eds): Progress in Bone Marrow Transplantation. New York, NY, Liss, 1987, p 423
13. Smith DM, Weisenburger DD, Bierman P, Kessinger A, Vaughan WP, Armitage J: Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 2:195, 1987
14. Hameroff SR, Otto CW, Kanell J, Weinstein PR, Blitt CD: Acute cardiovascular effects of dimethyl-sulfoxide. Ann NY Acad Sci 411:94, 1983
15. Styler MJ, Topolsky DL, Crilley PA, Covalesky V, Bryan R, Bulova S, Brodsky I: Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 10:435, 1992
16. Shlafer M, Matheny JL, Karow AM: Cardiac chronotropic mechanisms of dimethyl-sulfoxide: Inhibition of acetylcholinesterase and antagonism of negative chronotropy by atropine. Arch Int Pharmacodyn Ther 221:21, 1976
17. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ: Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 7:401, 1991
18. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B: Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804, 1992
19. Peggy D, Kemp N: Collection, storage, and administration of autologous bone marrow. Lancet 2:1426, 1960
20. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
21. Shpall EJ, Jones RB, Bearman SI, Purdy MH, Franklin WA, Heimfeld S, Berenson RJ: Transplantation of CD34+ hematopoietic progenitor cells. J Hematother 3:145, 1994
22. Rowley S, Sharkis S, Hattenburg C, Sensenbrenner L: Culture from human bone marrow of blast progenitor cells with an extensive proliferative capacity. Blood 69:804, 1987
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. PJ An Statis Assoc 53:457, 1958
24. Snedecor GW, Cochran WG: Statistical Methods. Ames, IA, Iowa State University Press, 1967
25. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM: Retrovirally-marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 88:3048, 1995
26. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
27. Henschler R, Brugger W, Luft T, Frey T, Mertelsmann R, Kanz L: Maintenance and transplantation potential in ex vivo human peripheral blood progenitor cells. Blood 84:2898, 1994
28. Brugger W, Heimfield S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
29. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994
30. Purdy MH, Hogan CJ, Hami L, McNiece I, Franklin W, Jones RB, Bearman SI, Berenson RJ, Cagnoni PJ, Heimfeld S, Shpall EJ: Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J Hematother 4:515, 1995
31. Muench M, Schneider J, Moore MA: Interactions among colony-stimulating factors, IL-1beta, IL-6, and Kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 20:339, 1992
32. + progenitor cells by stem cell factor, interleukin-1β (IL-β), IL-6, IL-3, interferon-γ, and erythropoietin. Blood 81:2579, 1993
33. Eaves CJ, Cashman JD, Eaves AC: Methodology of long-term culture of human hemopoietic cells. J Tissue Culture Methods 13:55, 1991